The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Phase 2 results: Encorafenib (ENCO) and cetuximab (CETUX) with or without alpelisib (ALP) in patients with advanced BRAF-mutant colorectal cancer (BRAFm CRC).
 
Josep Tabernero
Consulting or Advisory Role - Amgen; Boehringer Ingelheim; Celgene; Chugai Pharma; ImClone Systems; Lilly; Merck; Merck Serono; Millennium; Novartis; Roche/Genentech; Sanofi; Symphony Evolution; Taiho Pharmaceutical
 
Robin Van Geel
No Relationships to Disclose
 
Tormod Kyrre Guren
No Relationships to Disclose
 
Rona D. Yaeger
Research Funding - Genentech; GlaxoSmithKline; Novartis
 
Anna Spreafico
No Relationships to Disclose
 
Jason Edward Faris
Employment - Novartis
Consulting or Advisory Role - Merrimack; N-of-One
 
Takayuki Yoshino
Research Funding - Sumitomo Dainippon
 
Yasuhide Yamada
No Relationships to Disclose
 
Tae Won Kim
Honoraria - Amgen; Lilly
Research Funding - Bayer (Inst); Merck Serono (Inst); Roche (Inst)
 
Johanna C. Bendell
No Relationships to Disclose
 
Martin H. Schuler
Honoraria - Alexion Pharmaceuticals; Boehringer Ingelheim; Celgene; GlaxoSmithKline; Lilly; Novartis; Pfizer
Consulting or Advisory Role - AstraZeneca; Boehringer Ingelheim; Bristol-Myers Squibb; Celgene; Inanovate; Lilly; Novartis
Research Funding - Boehringer Ingelheim (Inst); Bristol-Myers Squibb (Inst); Novartis (Inst)
Patents, Royalties, Other Intellectual Property - University Duisburg-Essen
Travel, Accommodations, Expenses - Alexion Pharmaceuticals; AstraZeneca; Boehringer Ingelheim; Bristol-Myers Squibb; Celgene; GlaxoSmithKline; Inanovate; Lilly; Pfizer
 
Heinz-Josef Lenz
Honoraria - Bayer; Boehringer Ingelheim; Celgene; Merck Serono; Roche
Consulting or Advisory Role - Bayer; Merck Serono; Roche
Travel, Accommodations, Expenses - Bayer; Merck Serono; Roche
 
Ferry Eskens
Honoraria - Amgen; Ipsen; Merck; Pfizer
 
Jayesh Desai
Honoraria - Bayer; Merck Serono; Novartis
Consulting or Advisory Role - Amgen; Bayer; Bionomics; Circadian Technologies; Merck Serono; Novartis
Research Funding - GlaxoSmithKline (Inst); Novartis (Inst); Roche (Inst)
 
Howard S. Hochster
Consulting or Advisory Role - Amgen; Bayer; Boehringer Ingelheim; Bristol-Myers Squibb; Genentech; Sirtex Medical
Speakers' Bureau - Genomic Health
 
Emin Avsar
Employment - Novartis
Stock and Other Ownership Interests - Novartis
 
Tim Demuth
Employment - Novartis; Sandoz
Stock and Other Ownership Interests - Novartis
 
Victor Sandor
Employment - Array BioPharma; Incyte
Leadership - Array BioPharma; Incyte
Stock and Other Ownership Interests - Array BioPharma; Incyte
 
Elena Elez
Consulting or Advisory Role - Array BioPharma
 
Jan H.M. Schellens
No Relationships to Disclose